CN1426790A - 林蛙油软胶囊 - Google Patents
林蛙油软胶囊 Download PDFInfo
- Publication number
- CN1426790A CN1426790A CN01138864A CN01138864A CN1426790A CN 1426790 A CN1426790 A CN 1426790A CN 01138864 A CN01138864 A CN 01138864A CN 01138864 A CN01138864 A CN 01138864A CN 1426790 A CN1426790 A CN 1426790A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- frog oil
- forest frog
- oil soft
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 9
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 241000191896 Rana sylvatica Species 0.000 claims description 9
- 210000003101 oviduct Anatomy 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 241001122767 Theaceae Species 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000008524 evening primrose extract Nutrition 0.000 abstract 1
- 229940089020 evening primrose oil Drugs 0.000 abstract 1
- 239000010475 evening primrose oil Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000269436 Ranidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- -1 hydroxyl hydrogen Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011388641A CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011388641A CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1426790A true CN1426790A (zh) | 2003-07-02 |
CN1248597C CN1248597C (zh) | 2006-04-05 |
Family
ID=4674816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011388641A Expired - Fee Related CN1248597C (zh) | 2001-12-21 | 2001-12-21 | 林蛙油软胶囊 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1248597C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100415215C (zh) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | 一种野山茶油软胶囊 |
CN101120951B (zh) * | 2006-08-10 | 2010-05-12 | 孙欣 | 润巢软胶囊及其制作方法 |
CN102948663A (zh) * | 2012-12-19 | 2013-03-06 | 刘书新 | 一种林蛙油颗粒剂及其制备方法 |
CN103005460A (zh) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | 一种林蛙油抗衰老食品 |
CN105596424A (zh) * | 2016-02-04 | 2016-05-25 | 张菊明 | 哈桑抗压平衡养生胶囊及其制备方法 |
-
2001
- 2001-12-21 CN CNB011388641A patent/CN1248597C/zh not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100415215C (zh) * | 2005-11-11 | 2008-09-03 | 江西金海棠药用油有限公司 | 一种野山茶油软胶囊 |
CN101120951B (zh) * | 2006-08-10 | 2010-05-12 | 孙欣 | 润巢软胶囊及其制作方法 |
CN103005460A (zh) * | 2012-12-04 | 2013-04-03 | 吉林博大农林生物科技有限公司 | 一种林蛙油抗衰老食品 |
CN102948663A (zh) * | 2012-12-19 | 2013-03-06 | 刘书新 | 一种林蛙油颗粒剂及其制备方法 |
CN105596424A (zh) * | 2016-02-04 | 2016-05-25 | 张菊明 | 哈桑抗压平衡养生胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1248597C (zh) | 2006-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101373636B1 (ko) | 천연물 복합 발효 추출물을 유효성분으로 하는 피부 및 두피 상태 개선용 조성물 | |
CN102078283A (zh) | 一种中药美白祛斑营养乳膏 | |
CN104825347B (zh) | 一种医用生物美白袪斑敷料及其制备方法 | |
CN103432063B (zh) | 一种用于治疗青春痘色素沉斑和美白的精华液 | |
CN103417462B (zh) | 一种用于治疗青春痘色素沉斑和美白的面膜 | |
CN101791285B (zh) | 一种用于清除面部老年斑的黄皮酰胺复合纳米乳及其制备方法 | |
KR101374277B1 (ko) | 천연물 복합 발효 추출물을 유효성분으로 하는 발모제 조성물 | |
CN105267717A (zh) | 具有多重化妆品功效的天然草本植物药液及其应用 | |
CN101401779A (zh) | 含有复合植物多酚提取物的化妆品组合物及其制备方法 | |
CN102960602A (zh) | 一种芦荟保健粉 | |
CN103432064B (zh) | 一种用于治疗青春痘色素沉斑和美白的膏霜 | |
CN1248597C (zh) | 林蛙油软胶囊 | |
RU2283124C1 (ru) | Биологически активный препарат на основе морского растительного сырья | |
CN105963674A (zh) | 一种天然细胞修复剂及其制备方法 | |
CN105534858A (zh) | 植物精华粉及面膜霜和面膜粉 | |
CN102008083A (zh) | 一种缓解体力疲劳、祛黄褐斑的保健食品 | |
CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
CN103932941A (zh) | 营养元素抗衰护肤液 | |
CN101297705B (zh) | 复方藏羊胎素祛皱抗衰胶囊 | |
CN106937923A (zh) | 灵芝花粉护肤防衰霜 | |
CN102919853A (zh) | 林蛙油软胶囊 | |
CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
CN103860430B (zh) | 一种美容面膜及其制备方法 | |
CN113876676A (zh) | 一种石斛养颜霜及其制备方法 | |
CN102948663A (zh) | 一种林蛙油颗粒剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Free format text: FORMER OWNER: HARBIN JIANKANGREN SCIENCE AND SCIENCE CO. LTD. Effective date: 20050513 |
|
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050513 Address after: No. 36, water source road, Miyun Industrial Development Zone, Beijing Applicant after: Beijing Yishoutang Healthcare Technology Co. Ltd. Address before: 150090 No. 20, Harbin hi tech Development Zone, Nangang District, Heilongjiang, Hengshan Road Applicant before: Harbin Jiankangren Science and Science Co. Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HARBIN RED SUN HEALTH INDUSTRY GROUP CO., LTD. Free format text: FORMER OWNER: BEIJING YISHOUTANG HEALTH TECHNOLOGY CO.,LTD. Effective date: 20090612 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090612 Address after: Zip code at Bohai road and Weihai Road, Harbin, China: 150069 Co-patentee after: Yishoutang Health Technology Industry Co. Ltd. Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: No. 36, water source road, Miyun Industrial Development Zone, Beijing, China: 101500 Patentee before: Beijing Yishoutang Healthcare Technology Co. Ltd. |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice |
Addressee: Wang Baoshan Document name: Notification of Termination of Patent Right |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: YISHOU HALL HEALTH SCIENCE AND TECHNOLOGY INDUSTRY CO., LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110126 Address after: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Patentee after: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. Address before: 150069 Bohai road and Weihai Road intersection, cottage District, Harbin Co-patentee before: Yishoutang Health Technology Industry Co. Ltd. Patentee before: HARBIN HONGTAIYANG HEALTH INDUSTRY GROUP Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Baoguang Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060405 Termination date: 20171221 |